WO1997023631A3 - Globins containing binding domains - Google Patents

Globins containing binding domains Download PDF

Info

Publication number
WO1997023631A3
WO1997023631A3 PCT/US1996/020632 US9620632W WO9723631A3 WO 1997023631 A3 WO1997023631 A3 WO 1997023631A3 US 9620632 W US9620632 W US 9620632W WO 9723631 A3 WO9723631 A3 WO 9723631A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding domains
containing binding
globins
naturally occurring
domains
Prior art date
Application number
PCT/US1996/020632
Other languages
French (fr)
Other versions
WO1997023631A2 (en
Inventor
Spencer J Anthony-Cahill
Janet K Epp
Bruce A Kerwin
Peter O Olins
Antony J Mathews
Original Assignee
Somatogen Inc
Anthony Cahill Spencer J
Janet K Epp
Bruce A Kerwin
Peter O Olins
Antony J Mathews
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somatogen Inc, Anthony Cahill Spencer J, Janet K Epp, Bruce A Kerwin, Peter O Olins, Antony J Mathews filed Critical Somatogen Inc
Priority to EP96945282A priority Critical patent/EP0868521A2/en
Priority to JP9523865A priority patent/JP2000504934A/en
Priority to AU14689/97A priority patent/AU715914B2/en
Priority to US09/091,814 priority patent/US6218513B1/en
Priority to CA002239303A priority patent/CA2239303A1/en
Publication of WO1997023631A2 publication Critical patent/WO1997023631A2/en
Publication of WO1997023631A3 publication Critical patent/WO1997023631A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to globins containing non-naturally occurring binding domains. Such non-naturally occurring binding domains can be oligomerizing domains or can be ligand binding domains. The present invention also relates to multimeric hemoglobins comprised of at least one globin containing at least one non-naturally occurring binding domain.
PCT/US1996/020632 1995-12-22 1996-12-20 Globins containing binding domains WO1997023631A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP96945282A EP0868521A2 (en) 1995-12-22 1996-12-20 Globins containing binding domains
JP9523865A JP2000504934A (en) 1995-12-22 1996-12-20 Globin containing binding domain
AU14689/97A AU715914B2 (en) 1995-12-22 1996-12-20 Globins containing binding domains
US09/091,814 US6218513B1 (en) 1995-12-22 1996-12-20 Globins containing binding domains
CA002239303A CA2239303A1 (en) 1995-12-22 1996-12-20 Globins containing binding domains

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2100195P 1995-12-22 1995-12-22
US3200195P 1995-12-22 1995-12-22
US60/021,001 1995-12-22

Publications (2)

Publication Number Publication Date
WO1997023631A2 WO1997023631A2 (en) 1997-07-03
WO1997023631A3 true WO1997023631A3 (en) 1997-10-23

Family

ID=26694138

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/020632 WO1997023631A2 (en) 1995-12-22 1996-12-20 Globins containing binding domains

Country Status (1)

Country Link
WO (1) WO1997023631A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022849A (en) * 1987-05-16 2000-02-08 Baxter Biotech Technology Saarl Mutant recombinant hemoglobins containing heme pocket mutations
US6204009B1 (en) 1988-05-16 2001-03-20 BAXTER BIOTECH TECHNOLOGY SàRL Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations
CA2299049C (en) * 1997-05-02 2008-07-15 Baxter Biotech Technology S.A.R.L. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
EP1950298A3 (en) 1997-05-02 2008-12-24 Baxter Biotech Technology S.A.R.L. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
CA2454358A1 (en) * 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
KR101955928B1 (en) * 2016-12-30 2019-03-08 경상대학교산학협력단 Multimer fusion protein comprising hagfish VLRB hydrophobic tail domain

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013645A1 (en) * 1989-05-10 1990-11-15 Somatogen, Inc. Production in bacteria and yeast of hemoglobin and analogues thereof
WO1991019505A1 (en) * 1990-06-20 1991-12-26 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
WO1993009143A1 (en) * 1991-11-08 1993-05-13 Somatogen, Inc. Production and use of multimeric hemoglobins
WO1995014038A2 (en) * 1993-11-15 1995-05-26 Somatogen, Inc. Purification of hemoglobin
WO1996040920A1 (en) * 1992-11-06 1996-12-19 Somatogen, Inc. Modified hemoglobin-like compounds and methods of purifying same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013645A1 (en) * 1989-05-10 1990-11-15 Somatogen, Inc. Production in bacteria and yeast of hemoglobin and analogues thereof
WO1991019505A1 (en) * 1990-06-20 1991-12-26 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
WO1993009143A1 (en) * 1991-11-08 1993-05-13 Somatogen, Inc. Production and use of multimeric hemoglobins
WO1996040920A1 (en) * 1992-11-06 1996-12-19 Somatogen, Inc. Modified hemoglobin-like compounds and methods of purifying same
WO1995014038A2 (en) * 1993-11-15 1995-05-26 Somatogen, Inc. Purification of hemoglobin

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J.A. PIETENPOL ET AL.: "Sequence-specific transcriptional activation is essential for growth suppression by p53", PROC. NATL.ACAD SCI., vol. 91, March 1994 (1994-03-01), NATL. ACAD SCI.,WASHINGTON,DC,US;, pages 1998 - 2002, XP002039245 *
J.C. HU ET AL.: "Sequence requirements for coiled-coils: Analysis with lambda repressor-GCN4 leucine zipper fusions", SCIENCE, vol. 250, 7 December 1990 (1990-12-07), AAAS,WASHINGTON,DC,US, pages 1400 - 1403, XP002039244 *
P. PACK AND A. PLÜCKTHUN: "Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli", BIOCHEMISTRY, vol. 31, no. 6, 18 February 1992 (1992-02-18), AM. CHEM. SOC.,WASHINGTON,DC,US, pages 1579 - 1584, XP002039243 *
V.P. EFIMOV ET AL.: "The thrombospondin-like chain of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residue 20 and 83", FEBS LETTERS, vol. 341, no. 1, 14 March 1994 (1994-03-14), ELSEVIER, AMSTERDAM, NL, pages 54 - 58, XP002039242 *

Also Published As

Publication number Publication date
WO1997023631A2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
CA2187283A1 (en) Circularly permuted ligands and circularly permuted chimeric molecules
EP0143832A4 (en) Modified crosslinked stroma-free tetrameric hemoglobin.
WO2000018921A3 (en) Synthetic peptides having fgf receptor affinity
EP1961760A3 (en) Peptides and compounds that bind to a thrombopoietin receptor
BR9710538A (en) Binding metal content bleaching compositions
YU28199A (en) A novel compound form
CA2202239A1 (en) Liquid absorbent solutions for separating nitrogen from natural gas
AU6451194A (en) Hydrocarbon fractionation by adsorbent membranes
WO2000031124A3 (en) Peptides that modulate the interaction of b class ephrins and pdz domains
AU1678995A (en) Synergistic antifungal protein and compositions containing same
ZA948551B (en) Chimeric proteins comprising borrelia polypeptides; uses therefor
EP0661771A3 (en) Branching filter for transmitter-receiver.
AU7506694A (en) Bleach catalyst composition
WO1997023631A3 (en) Globins containing binding domains
EP0700684A3 (en) Composition containing prothrombincomplex-concentrate and at least one additional component which activates the coagulation, as antidote for blood-anticoagulants
WO2000034447A3 (en) Human ubiquitin ligase e3 for the modulation of nf-kappa b
DE69419240T2 (en) Catalyst for lowering the benzene content of gasolines
FR2772200B1 (en) ROUTING ACCESSORY FOR CHUTE, SUCH AS ANGLE OR BYPASS
WO2001011051A3 (en) Chimeric proteins
AU1261395A (en) Antibodies which inhibit the binding of thrombin to platelets
IE841297L (en) Aryloxycycloalkanolaminoalkylene aryl ketones.
WO2000031254A3 (en) Apoptosis-inducing factor
AU7238594A (en) Dying additive for protein fibers
EP0663235A4 (en) Phase separated membrane.
TR199701400A3 (en) Taste nutritional compositions.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

ENP Entry into the national phase

Ref document number: 2239303

Country of ref document: CA

Ref country code: CA

Ref document number: 2239303

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996945282

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09091814

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1996945282

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1996945282

Country of ref document: EP